13-108229249-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000375898.4(ABHD13):c.31G>A(p.Val11Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000765 in 1,568,524 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000375898.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABHD13 | NM_032859.3 | c.31G>A | p.Val11Ile | missense_variant | 2/2 | ENST00000375898.4 | NP_116248.2 | |
ABHD13 | XM_011521128.4 | c.31G>A | p.Val11Ile | missense_variant | 2/2 | XP_011519430.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABHD13 | ENST00000375898.4 | c.31G>A | p.Val11Ile | missense_variant | 2/2 | 1 | NM_032859.3 | ENSP00000365063 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152020Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000483 AC: 1AN: 206902Hom.: 0 AF XY: 0.00000906 AC XY: 1AN XY: 110400
GnomAD4 exome AF: 0.00000424 AC: 6AN: 1416504Hom.: 0 Cov.: 31 AF XY: 0.00000427 AC XY: 3AN XY: 702148
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152020Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74274
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.31G>A (p.V11I) alteration is located in exon 2 (coding exon 1) of the ABHD13 gene. This alteration results from a G to A substitution at nucleotide position 31, causing the valine (V) at amino acid position 11 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at